Previous Article | Next Article 
Journal of Virology, July 1999, p. 5490-5496, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Amelioration of Retroviral Vector Silencing in
Locus Control Region
-Globin-Transgenic Mice and Transduced F9
Embryonic Cells
Cameron S.
Osborne,1
Peter
Pasceri,1
Rakesh
Singal,2,
Tanya
Sukonnik,1
Gordon D.
Ginder,2,3 and
James
Ellis1,4,*
Programs in Developmental Biology and Blood
and Cancer Research, Hospital for Sick Children, Toronto, Ontario,
Canada M5G 1X81; Department of Molecular
and Medical Genetics, University of Toronto, Toronto, Ontario,
Canada4; Department of Medicine,
Division of Medical Oncology, University of Minnesota, Minneapolis,
Minnesota 55455-03622; and Massey Cancer
Center, Virginia Commonwealth University, Richmond, Virginia
23298-00373
Received 17 December 1998/Accepted 9 April 1999
Retroviral vectors are transcriptionally silenced in hematopoietic
stem cells, and this phenomenon must be overcome for effective gene
therapy of blood diseases. The murine stem cell virus (MSCV) vector
completely silences
-globin reporter genes regulated by locus
control region (LCR) elements 5'HS2 to 5'HS4 in seven of eight
transgenic mice. Here, we show that no single known MSCV silencer
element is sufficient for complete LCR
-globin transgene silencing.
However, partial silencing of high-copy transgenes is conveyed by the
MSCV direct repeat and promoter elements. The CpG methylation pattern
of silenced and expressed MSCV promoter transgenes is virtually
identical, demonstrating that silencing does not absolutely correlate
with methylation status. Combined mutations in all four MSCV silencer
elements leads to expression of
-globin in 6 of 10 transgenic mice.
The same mutations incorporated into the HSC1 retrovirus vector direct
neo gene expression in 71% of transduced F9 embryonic
carcinoma cells. These studies demonstrate that combined mutation of
four retroviral silencer elements relieves complete silencing in most
transgenic mice and transduced F9 cells and suggests that novel
silencer elements remain. Enhanced expression of the HSC1 vector in
primitive stem cells is well suited for blood gene therapy applications.
*
Corresponding author. Mailing address: Program in
Developmental Biology, Hospital for Sick Children, 555 University Ave., Toronto, Ontario, Canada M5G 1X8. Phone: (416) 813-7295. Fax: (416)
813-8883. E-mail: jellis{at}sickkids.on.ca.

Present address: Section of Hematology and Medical Oncology, LSU
Medical Center, Shreveport, LA 71130-3932.
Journal of Virology, July 1999, p. 5490-5496, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Swindle, C. S., Kim, H. G., Klug, C. A.
(2004). Mutation of CpGs in the Murine Stem Cell Virus Retroviral Vector Long Terminal Repeat Represses Silencing in Embryonic Stem Cells. J. Biol. Chem.
279: 34-41
[Abstract]
[Full Text]
-
Yao, S., Osborne, C. S., Bharadwaj, R. R., Pasceri, P., Sukonnik, T., Pannell, D., Recillas-Targa, F., West, A. G., Ellis, J.
(2003). Retrovirus silencer blocking by the cHS4 insulator is CTCF independent. Nucleic Acids Res
31: 5317-5323
[Abstract]
[Full Text]
-
Haas, D. L., Lutzko, C., Logan, A. C., Cho, G. J., Skelton, D., Jin Yu, X., Pepper, K. A., Kohn, D. B.
(2003). The Moloney Murine Leukemia Virus Repressor Binding Site Represses Expression in Murine and Human Hematopoietic Stem Cells. J. Virol.
77: 9439-9450
[Abstract]
[Full Text]
-
Staplin, W. R., Knezetic, J. A.
(2003). BVL-1-like VL30 promoter sustains long-term expression in erythroid progenitor cells. Blood
101: 1798-1800
[Abstract]
[Full Text]
-
Leimig, T., Mann, L., Martin, M. d. P., Bonten, E., Persons, D., Knowles, J., Allay, J. A., Cunningham, J., Nienhuis, A. W., Smeyne, R., d'Azzo, A.
(2002). Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells. Blood
99: 3169-3178
[Abstract]
[Full Text]
-
Shayakhmetov, D. M., Carlson, C. A., Stecher, H., Li, Q., Stamatoyannopoulos, G., Lieber, A.
(2002). A High-Capacity, Capsid-Modified Hybrid Adenovirus/Adeno-Associated Virus Vector for Stable Transduction of Human Hematopoietic Cells. J. Virol.
76: 1135-1143
[Abstract]
[Full Text]
-
Indraccolo, S., Minuzzo, S., Roccaforte, F., Zamarchi, R., Habeler, W., Stievano, L., Tosello, V., Klein, D., Gunzburg, W. H., Basso, G., Chieco-Bianchi, L., Amadori, A.
(2001). Effects of CD2 locus control region sequences on gene expression by retroviral and lentiviral vectors. Blood
98: 3607-3617
[Abstract]
[Full Text]
-
Wolfgang, M. J., Eisele, S. G., Browne, M. A., Schotzko, M. L., Garthwaite, M. A., Durning, M., Ramezani, A., Hawley, R. G., Thomson, J. A., Golos, T. G.
(2001). Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos. Proc. Natl. Acad. Sci. USA
98: 10728-10732
[Abstract]
[Full Text]
-
Schübeler, D., Lorincz, M. C., Cimbora, D. M., Telling, A., Feng, Y.-Q., Bouhassira, E. E., Groudine, M.
(2000). Genomic Targeting of Methylated DNA: Influence of Methylation on Transcription, Replication, Chromatin Structure, and Histone Acetylation. Mol. Cell. Biol.
20: 9103-9112
[Abstract]
[Full Text]
-
Zheng, H., Palese, P., García-Sastre, A.
(2000). Antitumor Properties of Influenza Virus Vectors. Cancer Res.
60: 6972-6976
[Abstract]
[Full Text]
-
Kalberer, C. P., Pawliuk, R., Imren, S., Bachelot, T., Takekoshi, K. J., Fabry, M., Eaves, C. J., London, I. M., Humphries, R. K., Leboulch, P.
(2000). From the Cover: Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta -globin in engrafted mice. Proc. Natl. Acad. Sci. USA
97: 5411-5415
[Abstract]
[Full Text]